Location History:
- Ann Arbor, MI (US) (2009)
- Ypsilanti, MI (US) (2010)
Company Filing History:
Years Active: 2009-2010
Title: Hemant Khanna: Innovator in Nephronophthisis Research
Introduction
Hemant Khanna is a prominent inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of nephrology, particularly in the study of Nephronophthisis, a genetic disorder that affects the kidneys. With a total of 2 patents, Khanna's work is pivotal in advancing our understanding of this condition.
Latest Patents
Khanna's latest patents include groundbreaking inventions related to NPH6 nucleic acids and proteins. The first patent focuses on the NPHP6 protein (nephrocystin-6) and nucleic acids encoding this protein. It also provides assays for the detection of NPHP6, as well as assays for identifying NPHP6 polymorphisms and mutations associated with various disease states. The second patent pertains to the NPHP5 protein (nephrocystin-5) and nucleic acids encoding it. Similar to the first, this invention offers assays for detecting NPHP5 polymorphisms and mutations linked to disease states.
Career Highlights
Hemant Khanna is affiliated with the University of Michigan, where he conducts his research and development. His work has garnered attention for its potential to improve diagnostic and therapeutic approaches for patients suffering from Nephronophthisis.
Collaborations
Khanna collaborates with notable colleagues, including Edgar A Otto and Anand Swaroop. Their combined expertise enhances the research efforts in nephrology and related fields.
Conclusion
Hemant Khanna's innovative contributions to nephrology, particularly through his patents on NPH6 and NPHP5 proteins, highlight his role as a key figure in advancing medical research. His work continues to pave the way for improved understanding and treatment of kidney diseases.